Position in ZYME
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,774,109
+$225,063 QoQ
Shares Held
70,851
+20.4% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZYME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERICAN CENTURY COMPANIES INC holds $3,844,388,733 across 170 Biotechnology names. ZYME ranks #76 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,802,363 | $596,347,845 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
562,097 | $434,298,626 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
813,285 | $363,164,283 | |
| 4 | ASND |
Ascendis Pharma A/S
|
1,397,119 | $319,563,028 | |
| 5 | INSM |
INSMED Inc
|
925,799 | $151,386,652 | |
| 6 | ARGX |
Argenx SE
|
173,700 | $126,844,425 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,663,803 | $124,934,967 | |
| 8 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
4,138,416 | $102,467,180 |
All Filings in ZYME
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,774,109 | 70,851 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,549,046 | 58,832 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $871,353 | 51,016 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $390,894 | 31,147 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $370,960 | 31,147 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $584,750 | 39,942 | Shares | Defined | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||